Pyruvate potentiates β-adrenergic inotropism of stunned guinea-pig myocardium

M. Isabel Tejero-Taldo, Jie Sun, James L. Caffrey, Robert T. Mallet

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

This study tested the hypotheses that the sensitivity of stunned myocardium to β-adrenergic stimulation is diminished, and that metabolic intervention with pyruvate can restore β-adrenergic responsiveness to pre-ischemic levels. Isolated working guinea-pig hearts metabolizing 10 mM glucose were stunned by 45 min of low flow ischemia, and pyruvate and/or isoproterenol treatments were initiated 15 and 30 min after reperfusion, respectively. The dose: response for cardiac power from 0.1-100 nM isoproterenol was significantly shifted to the right in stunned hearts: EC 50 (nM) increased from 0.3 ± 0.06 to 5.2 ± 1.86. Pyruvate (5 mM) largely restored isoproterenol responsiveness of stunned myocardium, lowering EC 50 to 1.1 ± 0.34 nM. Maximum power was similar in each group. Additional stunned hearts were treated with intermediate (2 nM) or high (30 nM) isoproterenol concentrations with or without pyruvate. Combining treatments produced a significant interaction at the low dose of isoproterenol, increasing cardiac power (mJ·min -1 ·g -1 ) to 149 ± 20, twice the sum of the individual treatments (2 nM isoproterenol: 34 ± 11; pyruvate: 33 ± 8). Cyclic AMP content was unaltered by isoproterenol or pyruvate alone but was increased 41% by the combination. Power was maximized by 30 nM isoproterenol, which tripled cyclic AMP content; pyruvate did not augment these responses, but lessened the isoproterenol-induced decline in cytosolic phosphorylation potential. Conclusions: β-adrenergic inotropism is attenuated in stunned myocardium, although the maximal response is unchanged. Pyruvate potentiated the effects of sub-maximal doses of isoproterenol without depleting cellular energy reserves further, and attenuated energy depletion by high doses of isoproterenol. Pyruvate may allow restoration of contractile performance with lower, energetically less costly doses of β-adrenergic agents.

Original languageEnglish
Pages (from-to)2327-2339
Number of pages13
JournalJournal of Molecular and Cellular Cardiology
Volume30
Issue number11
DOIs
StatePublished - 1 Jan 1998

Fingerprint

Muscle Contraction
Pyruvic Acid
Isoproterenol
Adrenergic Agents
Myocardium
Guinea Pigs
Myocardial Stunning
Cyclic AMP
Reperfusion
Ischemia
Phosphorylation
Glucose

Keywords

  • Adenylate cyclase
  • Antioxidants
  • Cardiac stunning
  • Cyclic AMP
  • Isoproterenol
  • Phosphocreatine
  • Pyruvate

Cite this

Tejero-Taldo, M. Isabel ; Sun, Jie ; Caffrey, James L. ; Mallet, Robert T. / Pyruvate potentiates β-adrenergic inotropism of stunned guinea-pig myocardium. In: Journal of Molecular and Cellular Cardiology. 1998 ; Vol. 30, No. 11. pp. 2327-2339.
@article{fdd41777f4fa47a897ec433ffea23c64,
title = "Pyruvate potentiates β-adrenergic inotropism of stunned guinea-pig myocardium",
abstract = "This study tested the hypotheses that the sensitivity of stunned myocardium to β-adrenergic stimulation is diminished, and that metabolic intervention with pyruvate can restore β-adrenergic responsiveness to pre-ischemic levels. Isolated working guinea-pig hearts metabolizing 10 mM glucose were stunned by 45 min of low flow ischemia, and pyruvate and/or isoproterenol treatments were initiated 15 and 30 min after reperfusion, respectively. The dose: response for cardiac power from 0.1-100 nM isoproterenol was significantly shifted to the right in stunned hearts: EC 50 (nM) increased from 0.3 ± 0.06 to 5.2 ± 1.86. Pyruvate (5 mM) largely restored isoproterenol responsiveness of stunned myocardium, lowering EC 50 to 1.1 ± 0.34 nM. Maximum power was similar in each group. Additional stunned hearts were treated with intermediate (2 nM) or high (30 nM) isoproterenol concentrations with or without pyruvate. Combining treatments produced a significant interaction at the low dose of isoproterenol, increasing cardiac power (mJ·min -1 ·g -1 ) to 149 ± 20, twice the sum of the individual treatments (2 nM isoproterenol: 34 ± 11; pyruvate: 33 ± 8). Cyclic AMP content was unaltered by isoproterenol or pyruvate alone but was increased 41{\%} by the combination. Power was maximized by 30 nM isoproterenol, which tripled cyclic AMP content; pyruvate did not augment these responses, but lessened the isoproterenol-induced decline in cytosolic phosphorylation potential. Conclusions: β-adrenergic inotropism is attenuated in stunned myocardium, although the maximal response is unchanged. Pyruvate potentiated the effects of sub-maximal doses of isoproterenol without depleting cellular energy reserves further, and attenuated energy depletion by high doses of isoproterenol. Pyruvate may allow restoration of contractile performance with lower, energetically less costly doses of β-adrenergic agents.",
keywords = "Adenylate cyclase, Antioxidants, Cardiac stunning, Cyclic AMP, Isoproterenol, Phosphocreatine, Pyruvate",
author = "Tejero-Taldo, {M. Isabel} and Jie Sun and Caffrey, {James L.} and Mallet, {Robert T.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1006/jmcc.1998.0792",
language = "English",
volume = "30",
pages = "2327--2339",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "11",

}

Pyruvate potentiates β-adrenergic inotropism of stunned guinea-pig myocardium. / Tejero-Taldo, M. Isabel; Sun, Jie; Caffrey, James L.; Mallet, Robert T.

In: Journal of Molecular and Cellular Cardiology, Vol. 30, No. 11, 01.01.1998, p. 2327-2339.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pyruvate potentiates β-adrenergic inotropism of stunned guinea-pig myocardium

AU - Tejero-Taldo, M. Isabel

AU - Sun, Jie

AU - Caffrey, James L.

AU - Mallet, Robert T.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - This study tested the hypotheses that the sensitivity of stunned myocardium to β-adrenergic stimulation is diminished, and that metabolic intervention with pyruvate can restore β-adrenergic responsiveness to pre-ischemic levels. Isolated working guinea-pig hearts metabolizing 10 mM glucose were stunned by 45 min of low flow ischemia, and pyruvate and/or isoproterenol treatments were initiated 15 and 30 min after reperfusion, respectively. The dose: response for cardiac power from 0.1-100 nM isoproterenol was significantly shifted to the right in stunned hearts: EC 50 (nM) increased from 0.3 ± 0.06 to 5.2 ± 1.86. Pyruvate (5 mM) largely restored isoproterenol responsiveness of stunned myocardium, lowering EC 50 to 1.1 ± 0.34 nM. Maximum power was similar in each group. Additional stunned hearts were treated with intermediate (2 nM) or high (30 nM) isoproterenol concentrations with or without pyruvate. Combining treatments produced a significant interaction at the low dose of isoproterenol, increasing cardiac power (mJ·min -1 ·g -1 ) to 149 ± 20, twice the sum of the individual treatments (2 nM isoproterenol: 34 ± 11; pyruvate: 33 ± 8). Cyclic AMP content was unaltered by isoproterenol or pyruvate alone but was increased 41% by the combination. Power was maximized by 30 nM isoproterenol, which tripled cyclic AMP content; pyruvate did not augment these responses, but lessened the isoproterenol-induced decline in cytosolic phosphorylation potential. Conclusions: β-adrenergic inotropism is attenuated in stunned myocardium, although the maximal response is unchanged. Pyruvate potentiated the effects of sub-maximal doses of isoproterenol without depleting cellular energy reserves further, and attenuated energy depletion by high doses of isoproterenol. Pyruvate may allow restoration of contractile performance with lower, energetically less costly doses of β-adrenergic agents.

AB - This study tested the hypotheses that the sensitivity of stunned myocardium to β-adrenergic stimulation is diminished, and that metabolic intervention with pyruvate can restore β-adrenergic responsiveness to pre-ischemic levels. Isolated working guinea-pig hearts metabolizing 10 mM glucose were stunned by 45 min of low flow ischemia, and pyruvate and/or isoproterenol treatments were initiated 15 and 30 min after reperfusion, respectively. The dose: response for cardiac power from 0.1-100 nM isoproterenol was significantly shifted to the right in stunned hearts: EC 50 (nM) increased from 0.3 ± 0.06 to 5.2 ± 1.86. Pyruvate (5 mM) largely restored isoproterenol responsiveness of stunned myocardium, lowering EC 50 to 1.1 ± 0.34 nM. Maximum power was similar in each group. Additional stunned hearts were treated with intermediate (2 nM) or high (30 nM) isoproterenol concentrations with or without pyruvate. Combining treatments produced a significant interaction at the low dose of isoproterenol, increasing cardiac power (mJ·min -1 ·g -1 ) to 149 ± 20, twice the sum of the individual treatments (2 nM isoproterenol: 34 ± 11; pyruvate: 33 ± 8). Cyclic AMP content was unaltered by isoproterenol or pyruvate alone but was increased 41% by the combination. Power was maximized by 30 nM isoproterenol, which tripled cyclic AMP content; pyruvate did not augment these responses, but lessened the isoproterenol-induced decline in cytosolic phosphorylation potential. Conclusions: β-adrenergic inotropism is attenuated in stunned myocardium, although the maximal response is unchanged. Pyruvate potentiated the effects of sub-maximal doses of isoproterenol without depleting cellular energy reserves further, and attenuated energy depletion by high doses of isoproterenol. Pyruvate may allow restoration of contractile performance with lower, energetically less costly doses of β-adrenergic agents.

KW - Adenylate cyclase

KW - Antioxidants

KW - Cardiac stunning

KW - Cyclic AMP

KW - Isoproterenol

KW - Phosphocreatine

KW - Pyruvate

UR - http://www.scopus.com/inward/record.url?scp=0032213777&partnerID=8YFLogxK

U2 - 10.1006/jmcc.1998.0792

DO - 10.1006/jmcc.1998.0792

M3 - Article

C2 - 9925369

AN - SCOPUS:0032213777

VL - 30

SP - 2327

EP - 2339

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 11

ER -